Edition:
United States

Zeba Siddiqui

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

Oct 16 2017

Thousands of new Rohingya refugees flee violence, hunger in Myanmar for Bangladesh

COX'S BAZAR/YANGON Hungry, destitute and scared, thousands of new Rohingya refugees crossed the border into Bangladesh from Myanmar early on Monday, Reuters witnesses said, fleeing hunger and attacks by Buddhist mobs that the United Nations has called ethnic cleansing.

Oct 04 2017

India gives blessing to Oppo stores as focus turns to Apple

MUMBAI India has given Chinese smartphone maker Oppo the go-ahead to open its own single-brand retail stores, boding well for rivals like Apple Inc which are seeking similar approvals.

Sep 22 2017

India's drug prices regulator calls for better oversight of private hospitals

MUMBAI India's drug pricing authority called for better regulation of the country's massive private healthcare industry on Friday to ensure government efforts to cut prices benefit patients.

Sep 18 2017

China's Fosun Pharma to buy smaller stake in India's Gland Pharma for $1.1 billion

BEIJING/MUMBAI Shanghai Fosun Pharmaceutical Group is trimming the size of the stake it will buy in India's Gland Pharma to 74 percent for $1.1 billion, in a bid to salvage the stalled deal that would be the biggest takeover by a Chinese firm in India.

Aug 23 2017

India's proposed pharma marketing rules hit legal roadblock

MUMBAI India's plan to bring in marketing rules to curb unethical promotional practices in the country's drug industry faces an indefinite delay after it hit a legal roadblock, marking a setback for public health groups.

Aug 22 2017

India grants Pfizer patent on pneumonia vaccine in blow to aid group

MUMBAI India has granted Pfizer Inc a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations.

Aug 22 2017

India grants Pfizer patent on pneumonia vaccine in blow to aid group

MUMBAI, Aug 22 India has granted Pfizer Inc a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations.

Aug 11 2017

Sun Pharma reports first-quarter loss as generics business suffers

India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a surprise quarterly loss on Friday due to one-off legal costs and pressure over prices in its largest market, the United States, casting a shadow over its growth prospects.

Aug 02 2017

No more freebies? India plans crackdown on marketing by drugmakers

MUMBAI India, one of the world's largest markets for pharmaceuticals is drawing up its first set of marketing rules for drugmakers, restricting gifts and trips offered to doctors and pharmacists to 1,000 rupees ($15), according to a draft proposal seen by Reuters.

Aug 02 2017

UPDATE 1-No more freebies? India plans crackdown on marketing by drugmakers

MUMBAI, Aug 2 India, one of the world's largest markets for pharmaceuticals is drawing up its first set of marketing rules for drugmakers, restricting gifts and trips offered to doctors and pharmacists to 1,000 rupees ($15), according to a draft proposal seen by Reuters.

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary